Description

2-(1,3-Dimethyl-2,6-Dioxo-1,2,3,6-Tetrahydro-7H-Purin-7-Yl)-n-[4-(1-Methylpropyl)Phenyl]Acetamide is a high-purity, non-nucleoside xanthine derivative of significant interest in advanced pharmaceutical research and development. This compound serves as a critical pharmacological reference standard and a key synthetic intermediate for creating novel therapeutic agents. It is primarily sought by pharmaceutical R&D laboratories, contract research organizations (CROs), and academic institutions engaged in drug discovery programs targeting adenosine receptor modulation.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel adenosine receptor antagonists and other xanthine-based drug candidates.
• Biochemical Research: Used as a reference compound in in vitro assays to study adenosine A1, A2A, and A2B receptor interactions and signaling pathways.
• Drug Discovery: Serves as a core scaffold for medicinal chemistry programs aimed at developing treatments for central nervous system (CNS) disorders, inflammatory conditions, and respiratory diseases.
• Analytical Standard: High-purity grade material used for method development, validation, and quality control in analytical laboratories (HPLC, LC-MS).
• Preclinical Studies: Utilized in pharmacological profiling and early-stage toxicology assessments of new chemical entities.

Basic Information

Product Name	2-(1,3-Dimethyl-2,6-Dioxo-1,2,3,6-Tetrahydro-7H-Purin-7-Yl)-n-[4-(1-Methylpropyl)Phenyl]Acetamide
CAS No.	332117-28-9
Molecular Formula	C19H23N5O3
Molecular Weight	369.42 g/mol
Synonyms	N-[4-(sec-Butyl)phenyl]-2-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)acetamide; 7-[2-[[4-(1-Methylpropyl)phenyl]amino]-2-oxoethyl]-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione; 2-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-[4-(sec-butyl)phenyl]acetamide; Xanthine derivative CAS 332117-28-9; sec-Butyl xanthine acetamide derivative
EINECS	Contact for details

Quality Control

Our 2-(1,3-Dimethyl-2,6-Dioxo-1,2,3,6-Tetrahydro-7H-Purin-7-Yl)-n-[4-(1-Methylpropyl)Phenyl]Acetamide is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and IR for structural confirmation, and residual solvent analysis. Certificates of Analysis (COA) detailing all specifications and test results are provided to ensure traceability and compliance with your research or development protocols.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound is light-sensitive; prolonged exposure to light should be avoided. Keep the container tightly sealed in a dry environment to minimize moisture uptake.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.